Magazine Article | August 9, 2017

Ipsen In The USA — Building & Leading The Subsidiary As Startup

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

Cynthia Schwalm, president, North American commercial operations for Ipsen, heads a historic initiative by a company few people on the west side of the Atlantic have ever heard of. It all started about three years ago when the company decided to take a literal leap and go where it had only stealthily gone before — into North America, with the United States as the primary goal.

Previously, outside of the U.S., Paris-based Ipsen had both specialty care and primary care businesses. It had conducted some basic R&D at a facility in Massachusetts and acquired several small biopharma companies that enabled it to be commercially active in the U.S. since 2009.